| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 11,063 | 8,344 | 8,639 | 9,566 | | Cost of Revenue | 3,499 | 3,585 | 3,466 | 3,381 | | | Gross Profit |
-
| 4,759 | 5,173 | 6,185 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,270 | 5,726 | 5,136 | 2,967 | | Non Recurring |
-
|
-
|
-
| 185 | | Others | 6,281 | 3,771 | 3,516 | 1,780 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (4,738) | (3,479) | 1,253 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (3,987) | (4,738) | (3,479) | 1,253 | | Interest Expense | 75 | 89 | 110 | 137 | | Income Before Tax | (4,062) | (4,827) | (3,589) | 1,116 | | Income Tax Expense |
-
| 10,608 | (1,687) | 429 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,062) | (15,435) | (1,902) | 687 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,062) | (15,435) | (1,902) | 687 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,062) | ($15,435) | ($1,902) | $687 |
|
0.51% Nasdaq 
0.0006 (0.09%) 
Income Statement
